Is Benitec Biopharma Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: BNTC) stock is to Buy BNTC stock.
Out of 1 analyst, 0 (0%) are recommending BNTC as a Strong Buy, 1 (100%) are recommending BNTC as a Buy, 0 (0%) are recommending BNTC as a Hold, 0 (0%) are recommending BNTC as a Sell, and 0 (0%) are recommending BNTC as a Strong Sell.
What is BNTC's forecast return on equity (ROE) for 2024-2027?
(NASDAQ: BNTC) forecast ROE is N/A, which is considered weak.
What is BNTC's Price Target?
According to 1 Wall Street analyst that have issued a 1 year BNTC price target, the average BNTC price target is $16.00, with the highest BNTC stock price forecast at $16.00 and the lowest BNTC stock price forecast at $16.00.
The Wall Street analyst predicted that Benitec Biopharma's share price could reach $16.00 by Apr 22, 2025. The average Benitec Biopharma stock price prediction forecasts a potential upside of 130.55% from the current BNTC share price of $6.94.
What is BNTC's forecast return on assets (ROA) for 2024-2027?
(NASDAQ: BNTC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.